Search

Items tagged with: RareDiseases

Middle East Rare Diseases Market | 2019 โ€“ 2030 | Ken Research

Middle East rare diseases treatment market is valued at USD 5 billion, driven by awareness, biotech advancements, and government initiatives in Saudi Arabia, UAE, and Israel.
www.kenresearch.com
#MiddleEast #healthcare #rarediseases #pharmaindustry

Soligenix reaches 50-patient milestone in Phase 3 HyBryte trial, showing 48% response rate for cutaneous T-cell lymphoma treatment. Promising results signal potential breakthrough in rare disease therapy. #Oncology #RareDiseases
#oncology #rarediseases

This website uses cookies to recognize revisiting and logged in users. You accept the usage of these cookies by continue browsing this website.

โ‡ง